Details
Stereochemistry | ACHIRAL |
Molecular Formula | C34H50N4O2.2Cl |
Molecular Weight | 617.692 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[Cl-].[Cl-].CC[N+](CC)(CCCNC1=CC(=O)C(NCCC[N+](CC)(CC)CC2=CC=CC=C2)=CC1=O)CC3=CC=CC=C3
InChI
InChIKey=WQRJZLXQCYZJEU-UHFFFAOYSA-N
InChI=1S/C34H48N4O2.2ClH/c1-5-37(6-2,27-29-17-11-9-12-18-29)23-15-21-35-31-25-34(40)32(26-33(31)39)36-22-16-24-38(7-3,8-4)28-30-19-13-10-14-20-30;;/h9-14,17-20,25-26H,5-8,15-16,21-24,27-28H2,1-4H3;2*1H
Molecular Formula | C34H50N4O2 |
Molecular Weight | 546.7864 |
Charge | 2 |
Count |
|
Stereochemistry | MIXED |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | ClH |
Molecular Weight | 36.461 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Doses
Dose | Population | Adverse events |
---|---|---|
12 mg single, intravenous Highest studied dose Dose: 12 mg Route: intravenous Route: single Dose: 12 mg Sources: |
unhealthy n = 1 Health Status: unhealthy Condition: anzesthesia Population Size: 1 Sources: |
Other AEs: Colic, Salivation... Other AEs: Colic (1 patient) Sources: Salivation (1 patient) Paresis (1 patient) |
AEs
AE | Significance | Dose | Population |
---|---|---|---|
Colic | 1 patient | 12 mg single, intravenous Highest studied dose Dose: 12 mg Route: intravenous Route: single Dose: 12 mg Sources: |
unhealthy n = 1 Health Status: unhealthy Condition: anzesthesia Population Size: 1 Sources: |
Paresis | 1 patient | 12 mg single, intravenous Highest studied dose Dose: 12 mg Route: intravenous Route: single Dose: 12 mg Sources: |
unhealthy n = 1 Health Status: unhealthy Condition: anzesthesia Population Size: 1 Sources: |
Salivation | 1 patient | 12 mg single, intravenous Highest studied dose Dose: 12 mg Route: intravenous Route: single Dose: 12 mg Sources: |
unhealthy n = 1 Health Status: unhealthy Condition: anzesthesia Population Size: 1 Sources: |
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:05:28 GMT 2023
by
admin
on
Fri Dec 15 15:05:28 GMT 2023
|
Record UNII |
O6HVT48T15
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C66886
Created by
admin on Fri Dec 15 15:05:28 GMT 2023 , Edited by admin on Fri Dec 15 15:05:28 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
m71
Created by
admin on Fri Dec 15 15:05:28 GMT 2023 , Edited by admin on Fri Dec 15 15:05:28 GMT 2023
|
PRIMARY | Merck Index | ||
|
CHEMBL1358790
Created by
admin on Fri Dec 15 15:05:28 GMT 2023 , Edited by admin on Fri Dec 15 15:05:28 GMT 2023
|
PRIMARY | |||
|
66373
Created by
admin on Fri Dec 15 15:05:28 GMT 2023 , Edited by admin on Fri Dec 15 15:05:28 GMT 2023
|
PRIMARY | |||
|
311-09-1
Created by
admin on Fri Dec 15 15:05:28 GMT 2023 , Edited by admin on Fri Dec 15 15:05:28 GMT 2023
|
PRIMARY | |||
|
O6HVT48T15
Created by
admin on Fri Dec 15 15:05:28 GMT 2023 , Edited by admin on Fri Dec 15 15:05:28 GMT 2023
|
PRIMARY | |||
|
9393
Created by
admin on Fri Dec 15 15:05:28 GMT 2023 , Edited by admin on Fri Dec 15 15:05:28 GMT 2023
|
PRIMARY | |||
|
C76787
Created by
admin on Fri Dec 15 15:05:28 GMT 2023 , Edited by admin on Fri Dec 15 15:05:28 GMT 2023
|
PRIMARY | |||
|
DTXSID401026554
Created by
admin on Fri Dec 15 15:05:28 GMT 2023 , Edited by admin on Fri Dec 15 15:05:28 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |